Onderneming Delta 9 Cannabis Inc Toronto S.E.
Aandelen
CA2477541049
Farmaceutische producten
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Retail Cannabis and Merchandise and Devices
86,1
%
| 52 | 82,8 % | 61 | 86,1 % | +16,92% |
Wholesale Cannabis
11,4
%
| 9 | 14,1 % | 8 | 11,4 % | -8,74% |
Business to Business
2,4
%
| 2 | 3,1 % | 2 | 2,4 % | -12,39% |
Verkoop per regio
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 63 | 100,0 % | 71 | 100,0 % | +12,39% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Arbuthnot
CEO | Chief Executive Officer | 34 | 01-01-12 |
James Lawson
DFI | Director of Finance/CFO | 73 | - |
Todd Schubert
CTO | Chief Tech/Sci/R&D Officer | - | - |
Mark Jonker
COO | Chief Operating Officer | - | 01-08-19 |
John Arbuthnot
BRD | Director/Board Member | 70 | 01-01-12 |
Ian Chadsey
IRC | Investor Relations Contact | - | 01-01-19 |
Kelsey Friesen
SAM | Sales & Marketing | - | - |
Marshall Posner
SAM | Sales & Marketing | - | - |
David Kideckel
PRN | Corporate Officer/Principal | - | 16-08-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hugh Aird
BRD | Director/Board Member | 70 | 07-09-18 |
Nitin Kaushal
CHM | Chairman | 58 | 31-10-17 |
John Arbuthnot
CEO | Chief Executive Officer | 34 | 01-01-12 |
John Arbuthnot
BRD | Director/Board Member | 70 | 01-01-12 |
Stuart Starkey
BRD | Director/Board Member | - | 19-12-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 296 177 103 | 244 981 486 ( 82,71 %) | 0 | 82,71 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+42,22% | 748 mld. | |
+34,11% | 598 mld. | |
-6,51% | 356 mld. | |
+17,79% | 325 mld. | |
+4,38% | 283 mld. | |
+17,02% | 245 mld. | |
+9,26% | 211 mld. | |
-4,21% | 209 mld. | |
+2,47% | 166 mld. |